Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart P Adler

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 3, 2006
Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipientsMark A Jacobson, Elizabeth Sinclair, Barry Bredt, et al.
The American Journal of Pathology|July 24, 2010
Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infectionEkaterina Maidji, Giovanni Nigro, Takako Tabata, et al.
Vaccine|May 17, 2006
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12Mark A Jacobson, Elizabeth Sinclair, Barry Bredt, et al.
Virus Genes|April 10, 2017
Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and ToledoNicolás M Suárez, Betty Lau, George M Kemble, et al.
Infectious Diseases in Obstetrics and Gynecology|May 9, 2007
Knowledge and awareness of congenital cytomegalovirus among womenJiyeon Jeon, Marcia Victor, Stuart P Adler, et al.
Vaccine|February 12, 2011
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cellsFrances M Saccoccio, Anne L Sauer, Xiaohong Cui, et al.
NPJ Vaccines|June 3, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trialLeike Li, Daniel C Freed, Yaping Liu, et al.
The Journal of Infectious Diseases|October 8, 2020
Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination With a Conditionally Replication-Defective Cytomegalovirus VaccineKara S Cox, Lu Zhang, Daniel C Freed, et al.
NPJ Vaccines|December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccinationFengsheng Li, Daniel C Freed, Aimin Tang, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesLawrence M Kauvar, Keyi Liu, Minha Park, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 3, 2006
Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipientsMark A Jacobson, Elizabeth Sinclair, Barry Bredt, et al.
The American Journal of Pathology|July 24, 2010
Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infectionEkaterina Maidji, Giovanni Nigro, Takako Tabata, et al.
Vaccine|May 17, 2006
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12Mark A Jacobson, Elizabeth Sinclair, Barry Bredt, et al.
Virus Genes|April 10, 2017
Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and ToledoNicolás M Suárez, Betty Lau, George M Kemble, et al.
Infectious Diseases in Obstetrics and Gynecology|May 9, 2007
Knowledge and awareness of congenital cytomegalovirus among womenJiyeon Jeon, Marcia Victor, Stuart P Adler, et al.
Vaccine|February 12, 2011
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cellsFrances M Saccoccio, Anne L Sauer, Xiaohong Cui, et al.
NPJ Vaccines|June 3, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trialLeike Li, Daniel C Freed, Yaping Liu, et al.
The Journal of Infectious Diseases|October 8, 2020
Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination With a Conditionally Replication-Defective Cytomegalovirus VaccineKara S Cox, Lu Zhang, Daniel C Freed, et al.
NPJ Vaccines|December 22, 2017
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccinationFengsheng Li, Daniel C Freed, Aimin Tang, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesLawrence M Kauvar, Keyi Liu, Minha Park, et al.
Pageof 6